Your browser doesn't support javascript.
loading
The Novel Diagnostic Index Based on HLA-DRB1 Genotype and PD-L1 Expression can Predict Severe irAEs in Patients with Metastatic Melanoma Taking Immune Checkpoint Inhibitors. The Results of the Pilot Study.
Zhukova, N; Orlova, R; Malkova, Anna; Kaledina, E; Demchenkova, A; Naimushina, P; Nazarov, V; Mazing, A; Lapin, S; Belyak, N; Shoenfeld, Y.
Afiliación
  • Zhukova N; Saint Petersburg State University, Saint Petersburg, Russia.
  • Orlova R; Saint Petersburg State University, Saint Petersburg, Russia.
  • Malkova A; Saint Petersburg State University, Saint Petersburg, Russia; Ariel University, Ariel, Israel.
  • Kaledina E; Saint Petersburg State University, Saint Petersburg, Russia.
  • Demchenkova A; Saint Petersburg State University, Saint Petersburg, Russia.
  • Naimushina P; Saint Petersburg State University, Saint Petersburg, Russia.
  • Nazarov V; Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia.
  • Mazing A; Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia.
  • Lapin S; Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia.
  • Belyak N; Saint Petersburg State University, Saint Petersburg, Russia.
  • Shoenfeld Y; Saint Petersburg State University, Saint Petersburg, Russia; Ariel University, Ariel, Israel.
Crit Rev Immunol ; 42(3): 1-9, 2022.
Article en En | MEDLINE | ID: mdl-37017622
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Crit Rev Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Rusia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Crit Rev Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Rusia